Todd Schlesinger, MD, FAAD - Optimizing Immunotherapy in Patients With Advanced Basal Cell Carcinoma: Practical Strategies to Inform Care

episode

CME in Minutes: Education in Dermatology not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Full Show Podcast: 23 September 2026 1h 29m · 22 Sep 2026 · The Mike Hosking Breakfast

Evening Wire: Trump Delivers Remarks to the UN & Nolan Wells Drowning Updates | 9.22.26 11 min · 22 Sep 2026 · Morning Wire

Willie Robertson Wouldn’t Let His Kids Open Their Own Gifts | Duck Call Room #589 59 min · 22 Sep 2026 · Duck Call Room

🎙Tell us your Group Chat Names - The Chat 10 min · 22 Sep 2026 · The Hauraki Breakfast Podcast

MORNING TEA: Taylor Swift's Surprise New Single & William and Kate Hit The Red Carpet With Tom Cruise 7 min · 22 Sep 2026 · The Spill

Trump Touts Foreign Policy Vision in UN Speech Ahead of Midterms 13 min · 22 Sep 2026 · WSJ What’s News

Report any issue

Source

Recorded13 Dec 2022

Publisherc.answersincme.com ↗

Handlerec:1447314

Show notes

Please visit answersincme.com/WZE860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in dermatology discusses strategies for optimizing immunotherapy in advanced basal cell carcinoma (BCC). Upon completion of this activity, participants should be better able to: Identify patients with advanced BCC who may benefit from immunotherapy; Review the clinical impact of available and emerging immunotherapies for the management of patients with advanced BCC; and Describe practical strategies to manage and monitor patients with advanced BCC on immunotherapy over both the long and short term.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in